Venlafaxine in Preventing Chronic Oxaliplatin-Induced Neuropathy In Patients Receiving Combination Chemotherapy
Status:
Completed
Trial end date:
2015-09-23
Target enrollment:
Participant gender:
Summary
You are being asked to take part in this research study because you are going to be treated
with oxaliplatin chemotherapy as part of your standard care. Oxaliplatin commonly causes
neuropathy (numbing, tingling and/or pain).The purpose of this study is to compare the
effects, good and/or bad, of venlafaxine with a placebo (an inactive agent) on
oxaliplatin-induced neuropathy (numbing, tingling and/or pain)